Literature DB >> 1978116

Cytomegalovirus and Rasmussen's encephalitis.

C Power1, S D Poland, W T Blume, J P Girvin, G P Rice.   

Abstract

In-situ hybridisation with a biotinylated cytomegalovirus (CMV) DNA probe was done on brain biopsy specimens from 10 patients with Rasmussen's encephalitis (RE) and 46 age-matched control patients with other neurological diseases. All 10 patients with RE had intractable epilepsy and focal neurological deficits, and there was perivascular cuffing, microglial nodules, astrogliosis, and neuronal loss. CMV genomic material was demonstrated in 7 of the 10 patients with RE (in neurons, astrocytes, oligodendrocytes, and endothelial cells) and in 2 of the 46 control patients. Probes for herpes simplex virus and hepatitis B virus were negative in all patients and in fibroblast controls. The results suggest that CMV is a likely cause of Rasmussen's encephalitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978116     DOI: 10.1016/0140-6736(90)92965-k

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.

Authors:  Hania Kebir; Lionel Carmant; François Fontaine; Kathie Béland; Ciprian M Bosoi; Nathalie T Sanon; Jorge I Alvarez; Sébastien Desgent; Camille L Pittet; David Hébert; Marie-Josée Langlois; Rose-Marie Rébillard; Dang K Nguyen; Cécile Cieuta-Walti; Gregory L Holmes; Howard P Goodkin; John R Mytinger; Mary B Connolly; Alexandre Prat; Elie Haddad
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 2.  Autoimmune encephalitis and its relation to infection.

Authors:  Arun Venkatesan; David R Benavides
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

Review 3.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 4.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 5.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

Review 6.  Development of anaplastic ependymoma in Rasmussen's encephalitis: review of the literature and case report.

Authors:  Raj Kumar; Abrar Ahad Wani; Jaypal Reddy; Lily Pal; Sunil Pradhan
Journal:  Childs Nerv Syst       Date:  2005-06-01       Impact factor: 1.475

7.  Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids.

Authors:  D Chinchilla; O Dulac; O Robain; P Plouin; G Ponsot; J F Pinel; D Graber
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies.

Authors:  M A Farrell; O Droogan; D L Secor; V Poukens; B Quinn; H V Vinters
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex.

Authors:  Martin Wirenfeldt; Ryan Clare; Spencer Tung; Alexander Bottini; Gary W Mathern; Harry V Vinters
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

10.  Elevated expression of EBV and TLRs in the brain is associated with Rasmussen's encephalitis.

Authors:  Xin Wang; Yisong Wang; Dong Liu; Peigang Wang; Dongying Fan; Yuguang Guan; Tianfu Li; Guoming Luan; Jing An
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.